Transcripta Bio

Transcripta Bio

Transcripta Bio is an AI-driven drug discovery startup focused on developing small molecule therapeutics to modulate gene expression disease signatures. The company aims to advance IND-enabling studies and clinical preparation for neurological diseases, including autism spectrum disorder and muscular dystrophy. Their innovative approach leverages robotic platforms and AI models to enhance drug discovery success rates.

Total raised
$24M
tracked to date
Latest round
$24M
Jul 23, 2026
Known investors
4
led by JAZZ Venture Partners

Is this your company?

Claim this profile to get matched with investors who fund Health startups in United States.

Claim this profile →

🏆 Featured in Datapile’s Q3 2026 USA Funding Report

Read the Q3 2026 USA report →
Add this badge to your site
<a href="https://datapile.co/reports/q3-2026-usa-startup-funding" target="_blank" rel="noopener" style="display:inline-flex;align-items:center;gap:8px;padding:9px 16px;border-radius:9999px;background:#0B1224;color:#ffffff;font:600 13px/1.2 -apple-system,BlinkMacSystemFont,'Segoe UI',Roboto,Arial,sans-serif;text-decoration:none;border:1px solid #7C5CFF"><span style="display:inline-block;width:11px;height:11px;border-radius:3px;background:#7C5CFF"></span>Featured in Datapile&rsquo;s Q3 2026 USA Funding Report</a>

Funding history

  1. 1
    $24MJul 23, 2026

    Led by JAZZ Venture Partners

    Announcement ↗

Founder

Chris Moxham
Chris Moxham
Founder & CEO

Investors in Transcripta Bio

Backers from this company's tracked funding rounds.

  • JJAZZ Venture PartnersLead investorVC firm
  • BBlueYard CapitalVC firm
  • MMayo ClinicVC firm
  • OOmnimedVC firm

Transcripta Bio in the news

Coverage of this company's funding, tracked by Datapile.

More Health companies

Recently funded startups in the same category.

Related on Datapile